Innovators (541353)

Score breakdown: P/E: 1/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• ROCE of 15% suggests decent capital efficiency, at least before the recent decline.
• Latest quarter remains profitable: ₹84 Cr sales and ₹5 Cr net profit.
• Stock has rallied from ₹102 to ₹224.10, indicating some market conviction about a recovery.
• Industrial products exposure could offer cyclical upside if demand revives.

Concerns

• Sales growth of -26.70% and profit growth of -37.17% show severe business deterioration.
• Piotroski F-Score of 3/9 points to weak financial health.
• P/E of 21.85 on declining earnings with zero dividend offers no margin of safety.
• Critical data missing—book value, debt/equity, promoter holding, ROE—makes the investment case incomplete.

AI Analysis

At ₹224, Innovators carries a market cap of ₹423 Cr, yet the business is shrinking: sales down 26.70% and profits down 37.17%. You would not know it from the chart—the stock sits near its 52-week high of ₹234.60, having doubled from ₹102. That is hope, not evidence. The P/E of 21.85 on falling earnings is far from Graham's bargain threshold. A Piotroski F-score of 3/9 reinforces my concern: this is a company with weak financial health, not a disciplined compounding machine. ROCE of 15% is respectable, but without book value, debt/equity, promoter holding, or ROE data, I am being asked to fly blind. In the latest quarter, sales were ₹84 Cr and net profit ₹5 Cr; that is a thin margin—roughly 6%—and insufficient to justify a premium multiple if the downtrend continues. I like industrial product businesses when they have pricing power and recurring customers. Here, I see no moat evidence, no dividend to pay me while I wait, and deteriorating fundamentals. Benjamin Graham taught me to treat a falling business with falling earnings as a warning, not a romance. The price action suggests the market smells a turnaround, but my investment discipline demands numbers, not narratives. At 21.85 times earnings, with negative growth and an F-score of 3/9, there is no margin of safety. This is a show-me story. I would wait on the sidelines until sales stabilise, profits grow, and the balance sheet becomes transparent. A wonderful business is not wonderful if you overpay; this one may not be wonderful at all.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer